IL6 and COVID-19: Severe COVID-19 is also known to cause the excessive release of inflammatory cytokines with high levels of interleukin 6 (IL-6) and maladaptive immune responses [19], thus leading to intrarenal inflammation, increased vascular permeability, and alterations of kidney microcirculation that result in renal hypoperfusion [17,18,20].